1. Home
  2. HNI vs LQDA Comparison

HNI vs LQDA Comparison

Compare HNI & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNI
  • LQDA
  • Stock Information
  • Founded
  • HNI 1944
  • LQDA 2004
  • Country
  • HNI United States
  • LQDA United States
  • Employees
  • HNI N/A
  • LQDA N/A
  • Industry
  • HNI Office Equipment/Supplies/Services
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNI Consumer Discretionary
  • LQDA Health Care
  • Exchange
  • HNI Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • HNI 2.1B
  • LQDA 1.9B
  • IPO Year
  • HNI N/A
  • LQDA 2018
  • Fundamental
  • Price
  • HNI $40.21
  • LQDA $25.30
  • Analyst Decision
  • HNI Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • HNI 1
  • LQDA 9
  • Target Price
  • HNI $70.00
  • LQDA $32.67
  • AVG Volume (30 Days)
  • HNI 515.6K
  • LQDA 2.4M
  • Earning Date
  • HNI 10-28-2025
  • LQDA 11-03-2025
  • Dividend Yield
  • HNI 3.38%
  • LQDA N/A
  • EPS Growth
  • HNI 16.22
  • LQDA N/A
  • EPS
  • HNI 2.98
  • LQDA N/A
  • Revenue
  • HNI $2,593,100,000.00
  • LQDA $69,216,000.00
  • Revenue This Year
  • HNI $5.80
  • LQDA $424.31
  • Revenue Next Year
  • HNI $3.78
  • LQDA $359.32
  • P/E Ratio
  • HNI $13.49
  • LQDA N/A
  • Revenue Growth
  • HNI 1.15
  • LQDA 343.41
  • 52 Week Low
  • HNI $39.66
  • LQDA $9.71
  • 52 Week High
  • HNI $58.42
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • HNI 26.53
  • LQDA 60.16
  • Support Level
  • HNI $44.23
  • LQDA $22.05
  • Resistance Level
  • HNI $46.46
  • LQDA $24.34
  • Average True Range (ATR)
  • HNI 1.14
  • LQDA 1.58
  • MACD
  • HNI -0.44
  • LQDA 0.26
  • Stochastic Oscillator
  • HNI 8.01
  • LQDA 63.31

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: